Skip to main content
Log in

Camrelizumab

Pneumonitis

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Deng C, et al. Case Report: Nintedanib for immune-related pneumonitis triggered by anti-PD-1 treatment in a patient with SMARCA4-mutant NSCLC: a case report. Frontiers in Pharmacology 14 : 1-6, Jan 2023. Available from: URL: https://dx.doi.org/10.3389/fphar.2023.1177329

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Camrelizumab. Reactions Weekly 1997, 39 (2024). https://doi.org/10.1007/s40278-024-53720-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-53720-1

Navigation